Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-2016 | 02-2016 | 11-2015 | 08-2015 | 05-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37 | 40 | 84 | 260 | 832 |
| Receivables | 15 | 44 | 35 | 31 | 22 |
| Inventories | 127 | 141 | 188 | 168 | 79 |
| TOTAL | $279 | $337 | $456 | $675 | $1,158 |
| Non-Current Assets | |||||
| PPE Net | 3 | 3 | 3 | N/A | N/A |
| Intangibles | 49 | 49 | 37 | 37 | 41 |
| TOTAL | $52 | $52 | $40 | $37 | $41 |
| Total Assets | $331 | $389 | $496 | $712 | $1,199 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 66 | 46 | 70 | 33 | 61 |
| TOTAL | $332 | $284 | $177 | $55 | $63 |
| Non-Current Liabilities | |||||
| Long Term Debt | 45 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 9 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 166 | 160 | 145 | 116 | 16 |
| TOTAL | $45 | $0 | $0 | $0 | $0 |
| Total Liabilities | $377 | $284 | $177 | $55 | $63 |
| Shareholders' Equity | |||||
| Common Shares | 46 | 45 | 40 | 40 | 40 |
| Retained earnings | -10,986 | -10,728 | -10,468 | -10,086 | -9,570 |
| Other shareholders' equity | 0 | 0 | 36 | 0 | -1 |
| TOTAL | $121 | $265 | $464 | $772 | $1,152 |
| Total Liabilities And Equity | $497 | $549 | $641 | $828 | $1,215 |